
Boric Acid (99.9% Granular) - Peru CAS: 10043-35-3

Chemical companies are entering 2026 with a renewed focus on cash flow, portfolio restructuring and selective investment rather than aggressive expansion. Procurement teams should understand how this strategy could affect production capacity, supplier priorities and long-term supply reliability.

Responsible Care performance indicators remain essential for supplier evaluation, but crisis conditions can influence operational results. This article explores how procurement and ESG teams can interpret 2026 KPI data with appropriate context while maintaining rigorous supplier assessments.

Drug shortages remained a major concern throughout H1 2026 as geopolitical disruptions, concentrated API production, and emerging demand for GLP-1 manufacturing inputs reshaped pharmaceutical procurement strategies for H2.

India's pharmaceutical industry is rapidly expanding GLP-1 API manufacturing capacity to meet growing global demand. Securing peptide raw materials and specialty solvents will be critical for maintaining production through H2 2026.

The 2026 Hormuz crisis has reshaped chemical logistics and sustainability metrics across global supply chains. From emissions accounting changes to sourcing diversification and ammonia project delays, procurement teams now face structural shifts that will persist beyond the immediate disruption.

China’s tightening export controls on herbicides, pesticides, and key fertilizer inputs have rattled global agrochemical supply chains. Buyers are diversifying suppliers, boosting inventories, and rethinking procurement strategies. The shift is reshaping the industry’s risk profile and trade patterns.
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.